By Chelsea Naso ( July 20, 2015, 5:54 PM EDT) -- Clinical-stage drug maker vTv Therapeutics Inc. set terms for a $125 million initial public offering Monday, laying the groundwork for the summer's second debut of an Alzheimer's disease treatment developer....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.